AWA
VRTX icon

Alta Wealth Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Alta Wealth Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$817K Sell
1,645
-21
-1% -$9.31K 0.22% 82
2026
Q1 		$744K Buy
1,666
+41
+3% +$19.1K 0.24% 80
2025
Q4 		$737K Buy
1,625
+29
+2% +$12.5K 0.25% 74
2025
Q3 		$625K Sell
1,596
-196
-11% -$81.9K 0.22% 77
2025
Q2 		$798K Hold
1,792
– – 0.38% 46
2025
Q1 		$869K Sell
1,792
-40
-2% -$18.6K 0.4% 56
2024
Q4 		$738K Buy
1,832
+5
+0.3% +$2.32K 0.32% 61
2024
Q3 		$850K Sell
1,827
-19
-1% -$9.13K 0.39% 57
2024
Q2 		$865K Sell
1,846
-2
-0.1% -$868 0.43% 54
2024
Q1 		$772K Sell
1,848
-12
-0.6% -$5.07K 0.39% 60
2023
Q4 		$757K Sell
1,860
-20
-1% -$7.39K 0.42% 63
2023
Q3 		$654K Sell
1,880
-200
-10% -$69.9K 0.4% 73
2023
Q2 		$732K Sell
2,080
-50
-2% -$16.8K 0.43% 67
2023
Q1 		$671K Hold
2,130
– – 0.42% 73
2022
Q4 		$615K Buy
+2,130
New +$649K 0.42% 80

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Alta Wealth Advisors's VRTX Position: Q2 2026 in Review

Alta Wealth Advisors reduced its Vertex Pharmaceuticals (VRTX) stake by 1.3% in Q2 2026, selling an estimated $9.31K and leaving 1,645 shares worth $817K. The position accounts for 0.22% of the portfolio, ranked #82.

Alta Wealth Advisors first reported a position in VRTX in Q4 2022 and has held it in 15 quarters since. The position peaked at $869K in Q1 2025. 1,749 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Alta Wealth Advisors held 1,645 shares of Vertex Pharmaceuticals worth $817K as of Q2 2026.
  • Alta Wealth Advisors sold 21 Vertex Pharmaceuticals shares in Q2 2026, an estimated $9.31K.
  • Vertex Pharmaceuticals made up 0.22% of Alta Wealth Advisors's portfolio in Q2 2026, its #82 holding.
  • Alta Wealth Advisors first reported a position in Vertex Pharmaceuticals in Q4 2022 and has held it in 15 quarters since.
  • Alta Wealth Advisors's Vertex Pharmaceuticals position peaked at $869K in Q1 2025.
  • 1,749 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Alta Wealth Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.